Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromfenac for Intraoperative Miosis and Pain Reduction in Cataract Surgery
NCT03831984Phase 4Unknown
- Sponsor
- Hospital de la Luz
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bromfenac sodium in cataract (2 arms), sponsored by Hospital de la Luz. Primary endpoint: Intraoperative miosis at 2 days. Status: unknown.
02
Drugs
bromfenac sodium
03
Conditions
cataract
Beyond the preview
Go deeper on NCT03831984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831984.